Financial Advisor to NB Renaissance for its investment in Neopharmed Gentili

Neopharmed Gentili, the leading group in the Italian pharmaceutical sector led by Alessandro Del Bono and a first-in-class management team, welcomes NB Renaissance, an investment firm focused on companies with high growth potential, as a new shareholder of the Group.

Moreover, the partnership with Ardian, a world leading private investment house, is renewed in order to continue the growth path started 4 years ago by setting further ambitious development projects.

This renewed agreement allows Neopharmed Gentili, Ardian and NB Renaissance to lay the foundations to continue on this growth path and confirm their will to support the company by providing new capital.

Intesa Sanpaolo's IMI Corporate & Investment Banking Division acted as Financial Advisor in this transaction.

Loading icon